Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Matthew S. Wieman"'
Autor:
Matthew S. Wieman, Frank E. Casty
Publikováno v:
Therapeutic innovationregulatory science. 47(3)
The traditional economic model for drug development by leading pharmaceutical companies in the developed world has yielded diminishing returns in recent years, with large pharmaceutical companies relying less on research and development and more on c
Publikováno v:
Postgraduate Medicine. 124:114-122
Opioids and antidepressants are frequently prescribed for chronic low back pain (cLBP). This post hoc analysis was conducted to assess the tolerability of oxymorphone extended release (ER) for cLBP in patients taking selective serotonin reuptake inhi
Publikováno v:
The American Journal of Geriatric Pharmacotherapy. 10:47-60
Nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with a dose-related risk of cardiovascular, renal, and gastrointestinal adverse events (AEs). Topical NSAIDs produce lower systemic NSAID exposure compared with oral NSAIDs, offering potent
Autor:
Matthew S. Wieman, Stephen F. Butler, Pronabesh DasMahapatra, Ryan A. Black, Theresa A. Cassidy
Publikováno v:
Pain medicine (Malden, Mass.). 15(3)
Objective The reformulation of oxycodone hydrochloride controlled-release (CR) tablets in August 2010 created a natural experiment at a national scale, providing an opportunity to evaluate patterns of abuse of prescription opioids and other drugs bef
Publikováno v:
Patient preference and adherence
Srinivas Nalamachu,1 Matthew Wieman,2 Leah Bednarek,2 Surya Chitra21International Clinical Research Institute, Overland Park, KS, 2Endo Pharmaceuticals Inc, Malvern, PA, USAPurpose: Lidocaine patch 5% is recommended as a first-line therapy for posthe
Publikováno v:
Journal of Pain Research
Charles E Argoff,1 Steven P Stanos,2 Matthew S Wieman31Department of Neurology, Albany Medical College Neurology Group, Albany, NY, USA; 2Rehabilitation Institute of Chicago, Center for Pain Management, Northwestern University Medical School, Feinber
Publikováno v:
Therapeutics and Clinical Risk Management
John H Peniston,1 Morris S Gold,2 Matthew S Wieman,3 Lawrence K Alwine41Feasterville Family Health Care Center, Feasterville, PA, 2Novartis Consumer Health, Inc, Parsippany, NJ, 3Endo Pharmaceuticals Inc, Malvern, PA, 4Downingtown Family Medicine, Do
Publikováno v:
Clinical Interventions in Aging
John H Peniston,1 Morris S Gold,2 Matthew S Wieman,3 Lawrence K Alwine41Feasterville Family Health Care Center, Feasterville, PA, 2Clinical Research and Biostatistics, Novartis Consumer Health Inc, Parsippany, NJ, 3Medical Affairs, Endo Pharmaceutica
Autor:
Roy D. Altman, Matthew S. Wieman, Richard A. Petruschke, Morris S. Gold, John H. Peniston, Edward Huskisson, Grigorios Fotopoulos
Publikováno v:
PM&R. 3
Publikováno v:
PM&R. 3